Hello,
Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:
- We've made lists of the top healthcare power players that you need to know;
- Some members of Congress have been investing in tobacco giants;
- Real-world data on how Pfizer's vaccine performs against the Omicron variant.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let's get to it…

From left: Dr. Isaac Kinde, head of research and innovation and a co-founder of Thrive, Dr. Asima Ahmad, Carrot Fertility cofounder and chief medical officer, Harpreet Singh Rai, Oura CEO, and Deena Shakir, Lux Capital partner.Thrive; Carrot Fertility; Oura; Deena Shakir; Samantha Lee/Insider
See the top power players influencing healthcare today, from Google execs to biotech VCs

- Dozens of investors and executives continuously shape US healthcare.
- We track the most important people in the industry, from new founders to legendary VCs.
- Here are the lists we've made about the healthcare power players you need to know.

iStock; Rebecca Zisser/Insider
Some of the same members of Congress pushing to restrict cigarettes and vapes are quietly investing in tobacco giants

- Smoking remains the largest preventable cause of death.
- Members of Congress have nevertheless invested in tobacco companies.
- Some lawmakers who have invested in such companies often speak out against tobacco.

A person is tested for COVID-19 in Johannesburg, South Africa, on Saturday November 27, 2021.AP Photo/Jerome Delay
2 doses of Pfizer's vaccine cut the risk of hospitalization by 70% during Omicron surge in South Africa, real-world study finds

- Pfizer's shot cut hospitalization risk by 70% during Omicron surge, compared with no vaccine, a study found.
- Glenda Gray, president of the South African Medical Research Council, said it was a drop from 93% during Delta wave, but boosters "will help".
- The study didn't confirm the cases were Omicron, so it's not possible to tell precise effectiveness against the variant.
More stories we're reading:
- CDC director: Early data suggests Omicron may be less severe, but 'a lot of people' will still get sick (Insider)
- 1 in every 100 elderly Americans has died from COVID-19 (The New York Times)
- Nurse who was the first person in the US to get vaccinated says healthcare workers are 'tired' and 'concerned' as the pandemic drags on (Insider)
- Merck's COVID-19 antiviral pill faces new challenges (Nature)
-Leah
Read the original article on Business Insider